Clinical Trial Update: A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan

View source ↗

Summary

A completed clinical trial evaluating the safety and efficacy of NovoSeven in patients with Glanzmann's thrombasthenia in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glanzmann Thrombasthenia

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Glanzmann's Disease | Status: COMPLETED